Also, the pharmacology of the Lively parts was largely uncharacterized, and confirmation of SCB use was hindered by an absence of recognized biomarkers. These knowledge gaps prompted experts across various disciplines to speedily (1) keep an eye on, recognize and quantify with chromatography/mass sp